Aralez Pharmaceuticals Inc. (ARLZ)

0.0429 -0.0066 (-13.333%)

IEX Real-Time Price

August 17, 2018 EST.

Nasdaq Global Select : Healthcare

Prev Close 0.0495

Price Open 0.0493

Volume: 4.6M

Avg Volume: 3.85M

Market Cap: 2.87M

P/E Ratio -0.03

52 Wk Range 0.0401-2.98



ARLZ Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-07-31
58.37M
2.97M
2.05
5.09%

2018-07-13
58.37M
2.96M
4.33
5.06%

2018-06-29
58.37M
3.45M
3.69
5.91%

2018-06-15
58.19M
3.38M
2.58
5.80%




ARLZ Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-08-08
Q2 2018
N/A
-0.28 (2)
0.00
0.00

2018-05-08
Q1 2018
N/A
-0.25 (3)
-0.29
-0.04

2018-03-13
Q4 2017
BTO
-0.34 (3)
-0.29
-0.04

2018-03-12
Q4 2017
N/A
-0.37 (2)
-0.29
-0.04

News

Aralez Pharma files for Chapter 11 bankruptcy; all assets to be sold; shares down 76% premarket (2018-08-10 07:44 SeekingAlpha)

Aralez Pharmaceuticals (NASDAQ: ARLZ ) plummets 76% premarket on increased volume after announcing that it has filed for Chapter 11 bankruptcy and will sell substantially all of its assets for $250M. More news on: Aralez Pharmaceuticals Inc., Healthcare stocks news, Merger &a…

 

Aralez Pharmaceuticals To Enter Into Purchase Agreements To Sell Substantially All Assets (2018-08-10 06:00 PR Newswire)

Transactions to be valued at an aggregate of U.S. $250 million Commences Voluntary Proceedings under CCAA in Canada and Chapter 11 in the United States Company to Continue Operating Business and Serving Customers As Usual MISSISSAUGA, Ontario , Aug. 10, 2018 /PRNewswire/…

 


Statistics

Shares Outstanding: 66.97M

Top 15 Institution Percent: 15.60

Price To Sales: 0.06

Price To Book: 6.23

Revenue: 51.96M

Gross Profit: 45.95M

Cash: 96.51M

Debt: N/A

Return On Assets: -23.31

Return On Equity: -253.46

Profit Margin: N/A

Price History

Beta: 0.13

50-day Moving Avg: 0.31

200-day Moving Avg: 1.16

YTD Change: -97.30

5-day Change: -34.00

1-month Change: -83.22

3-month Change: -90.30

6-month Change: -97.37

1-year Change: -96.20

Revenue Per Share: 1.00

Revenue Per Employee: 316805.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Aralez Pharmaceuticals Inc.

Exchange: Nasdaq Global Select

Industry: Drug Manufacturers

Sector: Healthcare

Website: http://www.aralez.com

Aralez Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in delivering products to improve patients' lives by acquiring, developing and commercializing products in cardiovascular, pain and other specialty areas.